Penn Davis Mcfarland Inc Pfizer Inc Transaction History

Penn Davis Mcfarland Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 19, 2021	SELL	$35.91 - $40.68 $219,302 - $248,432	-6,107 Closed	0 $0
Q1 2021 Apr 21, 2021	SELL	$33.49 - $37.77 $200,940 - $226,620	-6,000 Reduced 49.56%	6,107 $221,000
Q4 2020 Jan 22, 2021	BUY	$33.47 - $42.56 $11,580 - $14,725	346 Added 2.94%	12,107 $446,000
Q3 2020 Oct 28, 2020	BUY	$31.75 - $37.25 $373,411 - $438,097	11,761 New	11,761 $432,000
Q1 2020 Apr 20, 2020	SELL	$27.03 - $38.62 $155,719 - $222,489	-5,761 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$32.92 - $37.36 $6,254 - $7,098	190 Added 3.41%	5,761 $226,000
Q3 2019 Oct 25, 2019	BUY	$32.49 - $42.13 $181,001 - $234,706	5,571 New	5,571 $200,000

3,220

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Penn Davis Mcfarland Inc, based on Form 13F filings with the SEC.

Stay updated on Penn Davis Mcfarland Inc with notifications on news.